EQUBITS Licenses Foresight to Novartis and Johnson and Johnson
News Nov 01, 2005
EQUBITS have announced the first customers of their flagship product, EQUBITS Foresight. Customers include Novartis, Johnson and Johnson PRD, and BASF.
"After extensive testing and validation, customers are purchasing EQUBITS Foresight as an easy-to-use software solution for their data mining problems. Our customers expect a lot from new software and, as a result, evaluated and tested Equbits Foresight rigorously. By outperforming existing methods in customer evaluations, EQUBITS has established itself as a best in class, accurate, interpretable predictive modeling solution provider," says Ravi Mallela, VP of Marketing, EQUBITS LLC.
EQUBITS Foresight is being used to solve complex predictive modeling problems in the High Throughput Screening and ADME-Tox environments.
By applying EQUBITS Foresight to challenging predictive modeling problems, customers are generating more accurate, interpretable results.
"Equbits provides customers with data mining solutions that combine the accuracy of non-linear modeling with a level of interpretability provided by linear models," says Dr. Mallela.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019